Surgical treatment of drug-resistant tuberculosis

The Lancet Infectious Diseases

Volumn 12, Issue 2, 2012, Pages 157-166

  Kempker, Russell R ^a   Vashakidze, Sergo ^c   Solomonia, Nelly ^c   Dzidzikashvili, Nino ^c   Blumberg, Henry M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c National Center for Tuberculosis and Lung Diseases   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ALCOHOL; AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN; BCG VACCINE; CAPREOMYCIN; CLARITHROMYCIN; CLAVULANIC ACID; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; CASE REPORT; CASE STUDY; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE SEVERITY; DRUG SENSITIVITY; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEVER; GASTROINTESTINAL TOXICITY; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; SPUTUM CULTURE; SPUTUM EXAMINATION; STAINING; SURGICAL WARD; THORAX RADIOGRAPHY; THORAX SURGERY; WEIGHT REDUCTION;

ADULT; ANTITUBERCULAR AGENTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84856152250     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70244-4     Document Type: Review

References (74)

1. Koch R Classics in infectious diseases: the etiology of tuberculosis. Rev Infect Dis 1982, 4:1270-1274.
2. Sihoe AD, Shiraishi Y, Yew WW The current role of thoracic surgery in tuberculosis management. Respirology 2009, 14:954-968.
3. Perelman MI, Strelzov VP Surgery for pulmonary tuberculosis. World J Surg 1997, 21:457-467.
4. Tuffier T De la resection du sommet du poumon. Semin Med 1891, 11:202.
5. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010, WHO, World Health Organization, Geneva.
6. Guidelines for surveillance of drug resistance in tuberculosis 2009, WHO, World Health Organization, Geneva. 4th edn.
7. Global tuberculosis control: WHO report 2011 2011, WHO, World Health Organization, Geneva.
8. Raviglione MC Facing extensively drug-resistant tuberculosis-a hope and a challenge. N Engl J Med 2008, 359:636-638.
9. Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843.
10. Migliori GB, Sotgiu G, D'Arcy Richardson M, et al. MDR-TB and XDR-TB: drug resistance and treatment outcomes. Eur Respir J 2009, 34:778-779.
11. Caws M, Ha DT Scale-up of diagnostics for multidrug resistant tuberculosis. Lancet Infect Dis 2010, 10:656-658.
12. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009, 373:1861-1873.
13. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006, 55:301-305. Centers for Disease Control and Prevention.
14. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009, 33:871-881.
15. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015: WHO progress report 2011 2010, WHO, World Health Organization, Geneva.
16. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003, 167:603-662.
17. Global tuberculosis control: a short update to the 2009 report 2009, WHO, World Health Organization, Geneva.
18. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003, 348:119-128.
19. Olle-Goig JE, Sandy R Outcomes of individualised treatment for multidrug-resistant tuberculosis before DOTS-plus. Int J Tuberc Lung Dis 2005, 9:765-770.
20. Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:153-161.
21. Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med; 181: 80-86.
22. Eker B, Ortmann J, Migliori GB, et al. Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 2008, 14:1700-1706.
23. Leimane V, Dravniece G, Riekstina V, et al. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010, 36:584-593.
24. Burman WJ Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century. Clin Infect Dis 2010, 50(suppl 3):S165-S172.
25. Hastings J, Storks R A case of tuberculosis excavation of the left lung treated by perforation of the cavity through the walls of the chest 1844, Wilson and Ogilvy, London.
26. Forlanini C A contribuzione della terapia chirurgica della tisi; ablazione del polmone? pneumatorace artificiale?. Gazz Ospit 1882, 3:9-705.
27. Daniel T Collapse and mutilation. Captain of death: the story of tuberculosis 1997, 195-202. University of Rochester Press, Rochester, NY.
28. Meade R A history of thoracic surgery 1961, CC Thomas, Springfield, IL.
29. Carter BN The late results of thoracoplasty in the treatment of pulmonary tuberculosis. Ann Surg 1936, 104:552-559.
30. Freedlander SO Lobectomy in pulmonary tuberculosis: report of case. J Thorac Surg 1935, 5:132-142.
31. Lilienthal H Pneumonectomy for sarcoma of lung in tuberculosis patient. J Thorac Surg 1933, 2:600-611.
32. Francis RS, Curwen MP Major surgery for pulmonary tuberculosis: final report. Tubercle 1964, 45(suppl):5-79.
33. Mital OP, Agarwala MC Results of 150 resections for pulmonary tuberculosis. Indian J Chest Dis 1970, 12:83-90.
34. Snelling MR, Kam CM Treatment of 164 patients with chronic pulmonary tuberculosis by pneumonectomy in a developing country. Tubercle 1968, 49:187-191.
35. Saltini C Chemotherapy and diagnosis of tuberculosis. Respir Med 2006, 100:2085-2097.
36. Perelman MI Tuberculosis in Russia. Int J Tuberc Lung Dis 2000, 4:1097-1103.
37. Motus IY, Skorniakov SN, Sokolov VA, et al. Reviving an old idea: can artificial pneumothorax play a role in the modern management of tuberculosis?. Int J Tuberc Lung Dis 2006, 10:571-577.
38. Kang MW, Kim HK, Choi YS, et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010, 89:1597-1602.
39. Shiraishi Y, Katsuragi N, Kita H, Tominaga Y, Kariatsumari K, Onda T Aggressive surgical treatment of multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2009, 138:1180-1184.
40. Dravniece G, Cain KP, Holtz TH, Riekstina V, Leimane V, Zaleskis R Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis. Eur Respir J 2009, 34:180-183.
41. Park SK, Kim JH, Kang H, Cho JS, Smego RA Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Int J Infect Dis 2009, 13:170-175.
42. Orki A, Kosar A, Demirhan R, Saygi A, Arman B The value of surgical resection in patients with multidrug resistant tuberculosis. Thorac Cardiovasc Surg 2009, 57:222-225.
43. Wang H, Lin H, Jiang G Pulmonary resection in the treatment of multidrug-resistant tuberculosis: a retrospective study of 56 cases. Ann Thorac Surg 2008, 86:1640-1645.
44. Shiraishi Y, Katsuragi N, Kita H, Toishi M, Onda T Experience with pulmonary resection for extensively drug-resistant tuberculosis. Interact Cardiovasc Thorac Surg 2008, 7:1075-1078.
45. Mohsen T, Zeid AA, Haj-Yahia S Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience. J Thorac Cardiovasc Surg 2007, 134:194-198.
46. Naidoo R Active pulmonary tuberculosis: experience with resection in 106 cases. Asian Cardiovasc Thorac Ann 2007, 15:134-138.
47. Kir A, Inci I, Torun T, Atasalihi A, Tahaoglu K Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2006, 131:693-696.
48. Kim HJ, Kang CH, Kim YT, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J 2006, 28:576-580.
49. Somocurcio JG, Sotomayor A, Shin S, et al. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax 2007, 62:416-421.
50. Takeda S, Maeda H, Hayakawa M, Sawabata N, Maekura R Current surgical intervention for pulmonary tuberculosis. Ann Thorac Surg 2005, 79:959-963.
51. Park SK, Lee CM, Heu JP, Song SD A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2002, 6:143-149.
52. Chiang CY, Yu MC, Bai KJ, Suo J, Lin TP, Lee YC Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan. Int J Tuberc Lung Dis 2001, 5:272-277.
53. Pomerantz BJ, Cleveland JC, Olson HK, Pomerantz M Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001, 121:448-453.
54. van Leuven M, De Groot M, Shean KP, von Oppell UO, Willcox PA Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis. Ann Thorac Surg 1997, 63:1368-1372.
55. Treasure RL, Seaworth BJ Current role of surgery in Mycobacterium tuberculosis. Ann Thorac Surg 1995, 59:1405-1407.
56. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005, 9:640-645.
57. Protocol for the implementation of individualized treatment regimens for multi-drug resistant tuberculosis in resource-poor settings 1999, WHO, World Health Organization, Geneva.
58. Jeon DS, Kim DH, Kang HS, et al. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009, 13:594-600.
59. Kwon YS, Kim YH, Suh GY, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008, 47:496-502.
60. Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008, 372:1403-1409.
61. Kim DH, Kim HJ, Park SK, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008, 178:1075-1082.
62. Kim HR, Hwang SS, Kim HJ, et al. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 2007, 45:1290-1295.
63. Torun T, Tahaoglu K, Ozmen I, et al. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2007, 11:979-985.
64. Leimane V, Riekstina V, Holtz TH, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005, 365:318-326.
65. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004, 169:1103-1109.
66. Guidelines for the programmatic management of drug-resistant tuberculosis 2006, WHO, World Health Organization, Geneva.
67. Adjuvant Therapies and Strategies. The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis 2003, 29-32. Partners In Health, Partners in Health, Boston, MA.
68. Guidelines for the programmatic management of drug-resistant tuberculosis 2008, WHO, World Health Organization, Geneva.
69. Iseman MD, Madsen L, Goble M, Pomerantz M Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis 1990, 141:623-625.
70. Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J Cardiothorac Surg 1999, 16:187-193.
71. Olcmen A, Gunluoglu MZ, Demir A, Akin H, Kara HV, Dincer SI Role and outcome of surgery for pulmonary tuberculosis. Asian Cardiovasc Thorac Ann 2006, 14:363-366.
72. Kaplan G, Post FA, Moreira AL, et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 2003, 71:7099-7108.
73. Orlovic D, Smego RA Paradoxical tuberculosis reactions in HIV-infected patients. Int J Tuberc Lung Dis 2001, 5:370-375.
74. Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2010, 51:6-14.